SDIX | GenomeWeb

SDIX

NEW YORK (GenomeWeb News) – OriGene Technologies and SDIX today announced a definitive agreement for OriGene to buy the Life Science assets of SDIX for $16 million.

NEW YORK (GenomeWeb News) – Eppendorf this week opened its new UK headquarters in the Arlington Business Park in Stevenage.

NEW YORK (GenomeWeb News) – SDIX reported after the close of the market on Wednesday that its second-quarter revenues fell 10 percent year over year.

NEW YORK (GenomeWeb News) – SDIX reported after the close of the market on Thursday a 15 percent falloff year over year in first-quarter revenues.
The company also announced a deal with a top-10 drug firm to generate monoclonal antibodies against a GPCR target.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – SDIX today reported that its fourth-quarter revenues dipped 13 percent year over year, as its Life Science business dropped 11 percent.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – SDIX reported after the close of the market on Monday that revenues for the third quarter dropped 8 percent year over year.

The company's Life Science business improved 13 percent year over year as it expanded its product offerings and continued to invest in its Genomic Antibody technology.

Sales for its life science business increased 19 percent to $4.5 million, while food safety revenues jumped 28 percent to $1.8 million.

Despite the overall dip in revenues, the firm's life science sales increased 3 percent.

Pages

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.